Molecular Markers for Novel Therapeutic Strategies in Pancreatic Endocrine Tumors

Abstract

Results encourage further research into multidrug strategies incorporating inhibitors targeting IGF1R or Hsp90 and into studies of axitinib combined with conventional chemotherapeutics toxic to tumor cells in persistent growth arrest.